Document Detail

Screening for distress, the sixth vital sign, in lung cancer patients: effects on pain, fatigue, and common problems-secondary outcomes of a randomized controlled trial.
MedLine Citation:
PMID:  23147718     Owner:  NLM     Status:  Publisher    
BACKGROUND: This randomized controlled trial examined the impact of an online routine screening for distress program on physical symptoms and common psychosocial and practical problems in lung cancer outpatients. METHOD: Patients were randomly assigned to either the minimal screening group (the Distress Thermometer plus usual care); full screening group (Distress Thermometer, Canadian Problem Checklist (CPC), Pain Thermometer, Fatigue Thermometer, and the Psychological Screen for Cancer Part C, with a personalized report summarizing concerns); or triage (full screening plus option of personalized phone triage). Outcomes included pain, fatigue and psychosocial, practical and physical problems. Patients were reassessed 3 months later. RESULTS: A total of 549 lung patients completed baseline measures (89% of eligible patients) and 65.9% were retained at 3 months. At 3 months follow-up, significantly fewer patients in the triage group (32.1%) reported pain compared with the minimal screening group (49.6%), but the triage and full screening groups were not significantly different from one another. Patients in the triage group reported fewer problems with coping compared with the minimal and full screening groups and fewer problems with family conflict compared with the minimal screening group. Full screening patients reported fewer problems with breathlessness compared with the minimal screening group. No differences were found among groups in fatigue. Referrals were not associated with changes in outcomes over time. CONCLUSIONS: Routine screening for distress followed by personalized triage resulted in the most benefit for lung patients, with fewer fully screened and triaged patients reporting physical symptoms and psychosocial problems than those only minimally screened. Copyright © 2012 John Wiley & Sons, Ltd.
Linda E Carlson; Amy Waller; Shannon L Groff; Barry D Bultz
Related Documents :
2127788 - One-year treatment of chronic non-a, non-b hepatitis with interferon alfa-2b.
20236358 - Reduction of liver stiffness by interferon treatment in the patients with chronic hepat...
17713158 - Substitutions due to antiretroviral toxicity or contraindication in the first 3 years o...
15880608 - Long-term follow-up of peginterferon and lamivudine combination treatment in hbeag-posi...
20434658 - Arthroscopic ganglionectomy through an intrafocal cystic portal for wrist ganglia.
20065568 - Short-duration furazolidone therapy in combination with amoxicillin, bismuth subcitrate...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-12
Journal Detail:
Title:  Psycho-oncology     Volume:  -     ISSN:  1099-1611     ISO Abbreviation:  Psychooncology     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9214524     Medline TA:  Psychooncology     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 John Wiley & Sons, Ltd.
Department of Psychosocial Resources, Tom Baker Cancer Centre, Calgary, Alberta, Canada; Department of Oncology, University of Calgary, Calgary, Alberta, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Influence of FMO1 and 3 polymorphisms on serum olanzapine and its N-oxide metabolite in psychiatric ...
Next Document:  Multifunctional immune responses of HMBPP-specific V?2V?2 T cells in M. tuberculosis and other infec...